AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638 | +77.2% | 273,679 | +81.0% | 0.00% | 0.0% |
| Q2 2023 | $360 | +80.9% | 151,200 | +39.5% | 0.00% | – |
| Q1 2023 | $199 | +126.1% | 108,400 | +134.1% | 0.00% | – |
| Q4 2022 | $88 | -99.8% | 46,300 | +83.7% | 0.00% | – |
| Q3 2022 | $54,000 | +50.0% | 25,200 | +96.9% | 0.00% | – |
| Q2 2022 | $36,000 | -92.3% | 12,800 | -84.3% | 0.00% | -100.0% |
| Q1 2021 | $467,000 | -35.5% | 81,588 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $724,000 | +15.8% | 80,956 | +50.9% | 0.00% | 0.0% |
| Q3 2020 | $625,000 | -46.2% | 53,656 | -25.9% | 0.00% | 0.0% |
| Q2 2020 | $1,161,000 | +20.8% | 72,400 | -54.9% | 0.00% | 0.0% |
| Q1 2020 | $961,000 | +79.0% | 160,496 | +294.3% | 0.00% | – |
| Q4 2019 | $537,000 | -11.8% | 40,700 | -16.9% | 0.00% | -100.0% |
| Q3 2019 | $609,000 | -58.0% | 49,000 | -45.6% | 0.00% | 0.0% |
| Q2 2019 | $1,451,000 | – | 90,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |